OptiNose (NASDAQ: OPTN) reported Q3 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $23.55 million.

GUIDANCE:

OptiNose sees Q4 2022 revenue of $74-78 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.